Teleflex Incorporated (TBH.F)
| Previous close | 186.00 |
| Open | 185.00 |
| Bid | 188.00 x 10000 |
| Ask | 190.00 x 10000 |
| Day's range | 185.00 - 185.00 |
| 52-week range | 167.00 - 234.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 8.752B |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | 31.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.26 (0.68%) |
| Ex-dividend date | 14 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™ System for benign prostatic hyperplasia (BPH). This year’s research marks the first time results from two randomized head-to-
- GlobeNewswire
Teleflex Announces Quarterly Dividend
WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close of business on May 15, 2024. Additional information about Teleflex can be obtained from the company’s website at teleflex.com. About Teleflex Incorporated Teleflex is a global provider of medical technologies
- GlobeNewswire
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. First quarter financial summary Revenues of $737.8 million, up 3.8% compared to the prior year period; up 3.8% on a constant currency basisGAAP diluted EPS from continuing operations of $0.33, compared to $1.63 in the prior year periodAdjusted diluted EPS from continuing operations of $3.21, compared to $3.09 in the prior yea
